US Patent 7959925 Trimeric OX40-immunoglobulin fusion protein and methods of use
Patent 7959925 was granted and assigned to Providence Health System on June, 2011 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 7959925 Trimeric OX40-immunoglobulin fusion protein and methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
